1.
Morens DM, Fauci AS: The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007;195:1018-1028.
2.
Heron M: Deaths: Leading Causes for 2010. National Vital Statistics Reports. Hyattsville, National Center for Health Statistics, 2013, vol 62.
3.
Roger VL, Go AS, Lloyd-Jones DM, et al: Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011:123:e18-e209.
4.
Mensah GA, Brown DW: An overview of cardiovascular disease burden in the United States. Health Aff 2007;26:38-48.
5.
Heidenrich PA, Trogdon JG, Khavjou OA, et al: Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-944.
6.
Davis MM, Taubert K, Benin AL, et al: Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation 2006;114:1549-1553.
7.
Glezen WP, Decker M, Perrotta DM: Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 1987;136:550-555.
8.
Warren-Gash C, Smeeth L, Hayward AC: Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009;9:601-610.
9.
Davis MM, Taubert K, Benin AL, et al: Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation 2006;114:1549-1553.
10.
Howard PA, Kleoppel JW: Influenza vaccine for cardiovascular risk reduction. Hosp Pharm 2013;48:813-817.
11.
Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA: Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003;89:993-997.
12.
Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, et al: Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003;107:762-768.
13.
Vogel AJ, Brown DM: Single-dose CpG immunization protects against a heterosubtypic challenge and generates antigen-specific memory T cells. Front Immunol 2015;6:327.
14.
Grohskopf LA, Shay DK, Shimabukuro TT, et al; Centers for Disease Control and Prevention: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. MMWR Recomm Rep 2013;62(RR-07):1-43. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htm.
15.
DiazGranados CA, Dunning AJ, Kimmel M, et al: Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371:635-645.
16.
Hennekens CH, DeMets D: Statistical association and causation: contributions of different types of evidence. JAMA 2011;305:1134-1135.
17.
Centers for Disease Control and Prevention: Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003;52(RR-13):1-8.
18.
Hennekens CH, Buring JE: Epidemiology in Medicine. Boston, Little, Brown and Co, 1987, chapt 8.
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.